{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:38:08Z","timestamp":1781080688435,"version":"3.54.1"},"publisher-location":"Berlin, Heidelberg","reference-count":22,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642334320","type":"print"},{"value":"9783642334337","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/8904_2012_170","type":"book-chapter","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T04:05:24Z","timestamp":1345521924000},"page":"133-137","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic Efficacy of Magnesium Valproate in Succinic Semialdehyde Dehydrogenase Deficiency"],"prefix":"10.1007","author":[{"given":"Elena","family":"Vanadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip L.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Trapolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vanadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,22]]},"reference":[{"issue":"6","key":"170_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/humu.10288","volume":"22","author":"S Akaboshi","year":"2003","unstructured":"Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons GS, Maropoulos GD, Jakobs C, Grompe M, Gibson KM (2003) Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. Hum Mutat 22(6):442\u2013450","journal-title":"Hum Mutat"},{"issue":"1","key":"170_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2006.02.131","volume":"1090","author":"A Buzzi","year":"2006","unstructured":"Buzzi A, Wu Y, Frantseva MV, Perez Velazquez JL, Cortez MA, Liu CC, Shen LQ, Gibson KM, Snead OC 3rd (2006) Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function. Brain Res 1090(1):15\u201322","journal-title":"Brain Res"},{"issue":"4","key":"170_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrneurol.2011.25","volume":"7","author":"C Chiron","year":"2011","unstructured":"Chiron C, Dulac O (2011) Epilepsy: vigabatrin treatment and visual field loss. Nat Rev Neurol 7(4):189\u2013190","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"170_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.pbb.2004.09.008","volume":"79","author":"MA Cortez","year":"2004","unstructured":"Cortez MA, Wu Y, Gibson KM, Snead OC 3rd (2004) Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy. Pharmacol Biochem Behav 79(3):547\u2013553","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"170_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eplepsyres.2010.03.005","volume":"90","author":"Z D\u00f3sa","year":"2010","unstructured":"D\u00f3sa Z, Nieto-Gonzalez JL, Korshoej AR, Gibson KM, Jensen K (2010) Effect of gene dosage on single-cell hippocampal electrophysiology in a murine model of SSADH deficiency (gamma-hydroxybutyric aciduria). Epilepsy Res 90(1\u20132):39\u201346","journal-title":"Epilepsy Res"},{"issue":"5","key":"170_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.10752","volume":"54","author":"K Ergezinger","year":"2003","unstructured":"Ergezinger K, Jeschke R, Frauendienst-Egger G, Korall H, Gibson KM, Schuster VH (2003) Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency. Ann Neurol 54(5):686\u2013689","journal-title":"Ann Neurol"},{"issue":"2","key":"170_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF00711750","volume":"18","author":"KM Gibson","year":"1995","unstructured":"Gibson KM, Jakobs C, Ogier H, Hagenfeldt L, Eeg-Olofsson KE, Eeg-Olofsson O, Aksu F, Weber HP, Rossier E, Vollmer B et al (1995) Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 18(2):143\u2013146","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 6","key":"170_CR8","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1002\/ana.10626","volume":"54","author":"A Gropman","year":"2003","unstructured":"Gropman A (2003) Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency. Ann Neurol 54(Suppl 6):S66\u2013S72","journal-title":"Ann Neurol"},{"issue":"7","key":"170_CR9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/S1092852900016874","volume":"13","author":"I Knerr","year":"2008","unstructured":"Knerr I, Gibson KM, Jakobs C, Pearl PL (2008) Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients. CNS Spectr 13(7):598\u2013605","journal-title":"CNS Spectr"},{"issue":"5","key":"170_CR11","first-page":"962","volume":"38","author":"M Pandey","year":"2010","unstructured":"Pandey M, Gupta A, Baduni N, Vijfdar H, Sinha S, Jain A (2010) Refractory status epilepticus\u2013magnesium as rescue therapy. Anaesth Intensive Care 38(5):962","journal-title":"Anaesth Intensive Care"},{"issue":"9","key":"170_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/01.WNL.0000059549.70717.80","volume":"60","author":"PL Pearl","year":"2003","unstructured":"Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, Tuchman M (2003a) Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60(9):1413\u20131417","journal-title":"Neurology"},{"issue":"Suppl 6","key":"170_CR13","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1002\/ana.10629","volume":"54","author":"PL Pearl","year":"2003","unstructured":"Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM (2003b) Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol 54(Suppl 6):S73\u2013S80","journal-title":"Ann Neurol"},{"key":"170_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","volume":"73","author":"PL Pearl","year":"2009","unstructured":"Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S, Schreiber J, Forester K, Reeves-Tyer P, Liew C, Shamim S, Herscovitch P, Carson RE, Butman JA, Jakobs C, Theodore WH (2009) Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase (SSADH) deficiency. Neurology 73:423\u2013429","journal-title":"Neurology"},{"issue":"9","key":"170_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.braindev.2011.04.013","volume":"33","author":"PL Pearl","year":"2011","unstructured":"Pearl PL, Shukla L, Theodore WH, Jakobs C, Michael Gibson K (2011) Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. Brain Dev 33(9):796\u2013805","journal-title":"Brain Dev"},{"issue":"2","key":"170_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2011.01.065","volume":"492","author":"E Porras-Kattz","year":"2011","unstructured":"Porras-Kattz E, Harmony T, Ricardo-Garcell J, Gal\u00e1n L, Fern\u00e1ndez T, Prado-Alcal\u00e1 R, Avecilla-Ram\u00edrez G, S\u00e1nchez-Moreno L, Barrera-Res\u00e9ndiz J, Corsi-Cabrera M, Valencia-Sol\u00eds E (2011) Magnesium valproate in learning disabled children with interictal paroxysmal EEG patterns: preliminary report. Neurosci Lett 492(2):99\u2013104","journal-title":"Neurosci Lett"},{"issue":"3","key":"170_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","volume":"19","author":"RP Saneto","year":"2010","unstructured":"Saneto RP, Lee IC, Koenig MK, Bao X, Weng SW, Naviaux RK, Wong LJ (2010) POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19(3):140\u2013146","journal-title":"Seizure"},{"issue":"1","key":"170_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1570-0232(03)00276-9","volume":"792","author":"T Shinka","year":"2003","unstructured":"Shinka T, Ohfu M, Hirose S, Kuhara T (2003) Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency. J Chromatogr B Analyt Technol Biomed Life Sci 792(1):99\u2013106","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"170_CR20","first-page":"114","volume":"175","author":"S Simler","year":"1981","unstructured":"Simler S, Ciesielski L, Klein M, Gobaille S, Mandel P (1981) Mechanism of action ofan anticonvulsant, sodium dipropylacetate. C R Seances Soc Biol Fil 175(1):114\u2013119","journal-title":"C R Seances Soc Biol Fil"},{"issue":"2","key":"170_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00415-010-5721-2","volume":"258","author":"NA Visser","year":"2011","unstructured":"Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM (2011) Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 258(2):218\u2013222","journal-title":"J Neurol"},{"issue":"1","key":"170_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00139709-200423010-00002","volume":"23","author":"CG Wong","year":"2004","unstructured":"Wong CG, Chan KF, Gibson KM, Snead OC (2004) Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev 23(1):3\u201320","journal-title":"Toxicol Rev"},{"issue":"1","key":"170_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ana.20686","volume":"59","author":"Y Wu","year":"2006","unstructured":"Wu Y, Buzzi A, Frantseva M, Velazquez JP, Cortez M, Liu C, Shen L, Gibson KM, Snead OC 3rd (2006) Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms. Ann Neurol 59(1):42\u201352","journal-title":"Ann Neurol"},{"issue":"4","key":"170_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clinthera.2010.04.008","volume":"32","author":"LP Zou","year":"2010","unstructured":"Zou LP, Wang X, Dong CH, Chen CH, Zhao W, Zhao RY (2010) Three-week combination treatment with ACTH\u2009+\u2009magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China. Clin Ther 32(4):692\u2013700","journal-title":"Clin Ther"}],"container-title":["JIMD Reports","JIMD Reports - Case and Research Reports, 2012\/5"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2012_170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:02Z","timestamp":1557485882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2012_170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642334320","9783642334337"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/8904_2012_170","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}